IHE Holdings Information

IHE is an equity ETF with a total of 57 individual holdings. The top holdings are Johnson & Johnson stock at 24.80%, Eli Lilly and Company at 21.24%, Merck & Co. at 5.06%, Bristol-Myers Squibb Company at 5.02%, and Royalty Pharma at 4.49%.

Total Holdings

Top 10 Percentage

79.71%

Asset Class

Equity

ETF Category

Health

Assets

1.02B

PE Ratio

21.97

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	JNJ	Johnson & Johnson	24.80%	1,050,154
2	LLY	Eli Lilly and Company	21.24%	218,287
3	MRK	Merck & Co., Inc.	5.06%	444,374
4	BMY	Bristol-Myers Squibb Company	5.02%	847,096
5	RPRX	Royalty Pharma plc	4.49%	1,006,197
6	PFE	Pfizer Inc.	4.47%	1,682,691
7	ZTS	Zoetis Inc.	4.38%	367,407
8	VTRS	Viatris Inc.	4.29%	3,082,386
9	ELAN	Elanco Animal Health Incorporated	3.05%	1,329,713
10	JAZZ	Jazz Pharmaceuticals plc	2.91%	162,620
11	AXSM	Axsome Therapeutics, Inc.	1.81%	113,330
12	INDV	Indivior PLC	1.06%	334,200
13	LGND	Ligand Pharmaceuticals Incorporated	1.05%	52,683
14	CRNX	Crinetics Pharmaceuticals, Inc.	1.03%	274,396
15	TERN	Terns Pharmaceuticals, Inc.	0.97%	230,561
16	PBH	Prestige Consumer Healthcare Inc.	0.85%	128,582
17	CORT	Corcept Therapeutics Incorporated	0.83%	250,346
18	SUPN	Supernus Pharmaceuticals, Inc.	0.81%	153,495
19	TARS	Tarsus Pharmaceuticals, Inc.	0.75%	104,531
20	LQDA	Liquidia Corporation	0.65%	183,738
21	AMRX	Amneal Pharmaceuticals, Inc.	0.59%	453,786
22	EWTX	Edgewise Therapeutics, Inc.	0.54%	198,430
23	NKTR	Nektar Therapeutics	0.50%	72,056
24	WVE	Wave Life Sciences Ltd.	0.50%	386,946
25	OCUL	Ocular Therapeutix, Inc.	0.46%	456,128

Showing 25 of 57 holdings

Subscribe to see the full list

Activate Now

As of Mar 6, 2026